AAIC 2025 Abstract
Association of Occipital Amyloid PET Burden with ARIA‐E: Exploratory Analyses in Three Clinical Trials of Donanemab
Trial in peopleBiomarkers
Abstract
Background: Amyloid‐related imaging abnormalities including edema/effusions (ARIA‐E) occur with amyloid‐targeting therapies. Major risk factors for ARIA‐E include apolipoprotein (APOE) ε4 carrier status, microhemorrhages, and cerebral amyloid angiopathy (CAA).
